These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1176 related articles for article (PubMed ID: 9694911)

  • 1. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
    Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preischemic combination of the sodium-hydrogen exchanger inhibitor cariporide and the adenosine agonist AMP579 acts additively to reduce porcine myocardial infarct size.
    Kristo G; Yoshimura Y; Ferraris SP; Jahania SA; Mentzer RM; Lasley RD
    J Am Coll Surg; 2004 Oct; 199(4):586-94. PubMed ID: 15454144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular pharmacology of the adenosine A1/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium.
    McVey MJ; Smits GJ; Cox BF; Kitzen JM; Clark KL; Perrone MH
    J Cardiovasc Pharmacol; 1999 May; 33(5):703-10. PubMed ID: 10226856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of ischemia/reperfusion-induced myocardial infarction by the 2-alkynyladenosine derivative 2-octynyladenosine (YT-146).
    Sasamori J; Aihara K; Yoneyama F; Sato I; Kogi K; Takeo S
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):614-20. PubMed ID: 16680077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment with an adenosine A1 receptor agonist and lidocaine: a possible alternative to myocardial ischemic preconditioning.
    Canyon SJ; Dobson GP
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):371-7. PubMed ID: 16077401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitation of infarct size in rabbit hearts by the novel adenosine receptor agonist AMP 579 administered at reperfusion.
    Xu Z; Yang XM; Cohen MV; Neumann T; Heusch G; Downey JM
    J Mol Cell Cardiol; 2000 Dec; 32(12):2339-47. PubMed ID: 11113009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Limb ischemic preconditioning reduces infarct size following myocardial ischemia-reperfusion in rats].
    Dong JH; Liu YX; Ji ES; He RR
    Sheng Li Xue Bao; 2004 Feb; 56(1):41-6. PubMed ID: 14985828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous AMP 579, a novel adenosine A(1)/A(2a) receptor agonist, induces a delayed protection against myocardial infarction in minipig.
    Meng H; McVey M; Perrone M; Clark KL
    Eur J Pharmacol; 2000 Jan; 387(1):101-5. PubMed ID: 10633167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal morphine preconditioning induces cardioprotection via activation of delta, kappa, and mu opioid receptors in rats.
    Li R; Wong GT; Wong TM; Zhang Y; Xia Z; Irwin MG
    Anesth Analg; 2009 Jan; 108(1):23-9. PubMed ID: 19095826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs.
    Vander Heide RS; Reimer KA
    Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of body temperature on myocardial protection conferred by ischaemic preconditioning or the selective adenosine A1 receptor agonist GR79236, in an anaesthetized rabbit model of myocardial ischaemia and reperfusion.
    Sheldrick A; Gray KM; Drew GM; Louttit JB
    Br J Pharmacol; 1999 Sep; 128(2):385-95. PubMed ID: 10510449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative importance of adenosine A1 and A3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart.
    Hill RJ; Oleynek JJ; Magee W; Knight DR; Tracey WR
    J Mol Cell Cardiol; 1998 Mar; 30(3):579-85. PubMed ID: 9515033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effects of 17 beta-estradiol produced by activation ofmitochondrial ATP-sensitive K(+)Channels in canine hearts.
    Lee TM; Su SF; Tsai CC; Lee YT; Tsai CH
    J Mol Cell Cardiol; 2000 Jul; 32(7):1147-58. PubMed ID: 10860759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acadesine reduces myocardial infarct size by an adenosine mediated mechanism.
    Zhao ZQ; Williams MW; Sato H; Hudspeth DA; McGee DS; Vinten-Johansen J; Van Wylen DG
    Cardiovasc Res; 1995 Apr; 29(4):495-505. PubMed ID: 7796443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARD-353 [4-((2R,5S)-4-(R)-(4-diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic acid], a novel nonpeptide delta receptor agonist, reduces myocardial infarct size without central effects.
    Watson MJ; Holt JD; O'Neill SJ; Wei K; Pendergast W; Gross GJ; Gengo PJ; Chang KJ
    J Pharmacol Exp Ther; 2006 Jan; 316(1):423-30. PubMed ID: 16188952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-infarct effect of an adenosine A1-selective agonist is diminished after prolonged infusion as is the cardioprotective effect of ischaemic preconditioning in rabbit heart.
    Tsuchida A; Thompson R; Olsson RA; Downey JM
    J Mol Cell Cardiol; 1994 Mar; 26(3):303-11. PubMed ID: 8028014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
    Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
    Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
    Balakumar P; Singh H; Reddy K; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion model.
    Dai W; Hale SL; Kay GL; Jyrala AJ; Kloner RA
    Cardiovasc Ther; 2010; 28(1):30-7. PubMed ID: 20074257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion.
    Liu X; Huang Y; Pokreisz P; Vermeersch P; Marsboom G; Swinnen M; Verbeken E; Santos J; Pellens M; Gillijns H; Van de Werf F; Bloch KD; Janssens S
    J Am Coll Cardiol; 2007 Aug; 50(8):808-17. PubMed ID: 17707188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.